Thirty-seven years later, Margolius et al. [59] described lower levels of urinary kallikrein in patients with essential hypertension than in a control population, and normal levels in patients with renal artery stenosis, and raised levels in patients with pheochromocytoma and primary aldosteronism. Here, KLK4 is linked to hypertensive disorder.